National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, & ebrary, Inc. (2011). Risk-characterization framework for decision-making at the food and drug administration. National Academies Press.
芝加哥风格引文National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, 与 Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. Washington, DC: National Academies Press, 2011.
MLA引文National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, 与 Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. National Academies Press, 2011.